Network analysis of patterns and relevance of enteric pathogen co-infections among infants in a diarrhea-endemic setting.
Autorzy:
Colgate ER; Translational Global Infectious Disease Research Center, University of Vermont, Burlington, Vermont, United States of America.; Department of Microbiology and Molecular Genetics, University of Vermont, Burlington, Vermont, United States of America. Klopfer C; Vermont Complex Systems Center, University of Vermont, Burlington, Vermont, United States of America. Dickson DM; Translational Global Infectious Disease Research Center, University of Vermont, Burlington, Vermont, United States of America.; Department of Microbiology and Molecular Genetics, University of Vermont, Burlington, Vermont, United States of America. Lee B; Translational Global Infectious Disease Research Center, University of Vermont, Burlington, Vermont, United States of America.; Department of Pediatrics, University of Vermont Larner College of Medicine, Burlington, Vermont, United States of America. Wargo MJ; Translational Global Infectious Disease Research Center, University of Vermont, Burlington, Vermont, United States of America.; Department of Microbiology and Molecular Genetics, University of Vermont, Burlington, Vermont, United States of America. Alam A; International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh. KirkpatrickBD; Translational Global Infectious Disease Research Center, University of Vermont, Burlington, Vermont, United States of America.; Department of Microbiology and Molecular Genetics, University of Vermont, Burlington, Vermont, United States of America. Hébert-Dufresne L; Translational Global Infectious Disease Research Center, University of Vermont, Burlington, Vermont, United States of America.; Vermont Complex Systems Center, University of Vermont, Burlington, Vermont, United States of America.; Department of Computer Science, University of Vermont, Burlington, Vermont, United States of America.
Pokaż więcej
Źródło:
PLoS computational biology [PLoS Comput Biol] 2023 Nov 22; Vol. 19 (11), pp. e1011624. Date of Electronic Publication: 2023 Nov 22 (Print Publication: 2023).
Maternal Breast Milk Secretor Phenotype Does Not Affect Infant Susceptibility to Rotavirus Diarrhea.
Autorzy:
Williams FB; Vaccine Testing Center and Translational Global Infectious Diseases Research Center, Larner College of Medicine, University of Vermont, Burlington, Vermont, USA. Kader MA; International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh. Dickson DM; Vaccine Testing Center and Translational Global Infectious Diseases Research Center, Larner College of Medicine, University of Vermont, Burlington, Vermont, USA. Colgate ER; Vaccine Testing Center and Translational Global Infectious Diseases Research Center, Larner College of Medicine, University of Vermont, Burlington, Vermont, USA. Alam M; International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh. Haque R; International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh. Petri WA Jr; Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, Virginia, USA. KirkpatrickBD; Vaccine Testing Center and Translational Global Infectious Diseases Research Center, Larner College of Medicine, University of Vermont, Burlington, Vermont, USA. Lee B; Vaccine Testing Center and Translational Global Infectious Diseases Research Center, Larner College of Medicine, University of Vermont, Burlington, Vermont, USA.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2023 Jun 07; Vol. 10 (6), pp. ofad299. Date of Electronic Publication: 2023 Jun 07 (Print Publication: 2023).
Plasma VP8∗-Binding Antibodies in Rotavirus Infection and Oral Vaccination in Young Bangladeshi Children.
Autorzy:
Lee B; Department of Pediatrics, Division of Pediatric Infectious Diseases, University of Vermont Larner College of Medicine, Burlington, Vermont, USA.; Translational Global Infectious Diseases Research Center, University of Vermont Larner College of Medicine, Burlington, Vermont, USA. Colgate ER; Translational Global Infectious Diseases Research Center, University of Vermont Larner College of Medicine, Burlington, Vermont, USA.; Department of Microbiology and Molecular Genetics, University of Vermont Larner College of Medicine, Burlington, Vermont, USA. Carmolli M; Translational Global Infectious Diseases Research Center, University of Vermont Larner College of Medicine, Burlington, Vermont, USA.; Department of Microbiology and Molecular Genetics, University of Vermont Larner College of Medicine, Burlington, Vermont, USA. Dickson DM; Translational Global Infectious Diseases Research Center, University of Vermont Larner College of Medicine, Burlington, Vermont, USA.; Department of Microbiology and Molecular Genetics, University of Vermont Larner College of Medicine, Burlington, Vermont, USA. Gullickson S; Translational Global Infectious Diseases Research Center, University of Vermont Larner College of Medicine, Burlington, Vermont, USA.; Department of Microbiology and Molecular Genetics, University of Vermont Larner College of Medicine, Burlington, Vermont, USA. Diehl SA; Translational Global Infectious Diseases Research Center, University of Vermont Larner College of Medicine, Burlington, Vermont, USA.; Department of Microbiology and Molecular Genetics, University of Vermont Larner College of Medicine, Burlington, Vermont, USA. Ara R; Department of Parasitology and Emerging Infections, International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh. Alam M; Department of Parasitology and Emerging Infections, International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh. Kibria G; Department of Parasitology and Emerging Infections, International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh. Abdul Kader M; Department of Parasitology and Emerging Infections, International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh. Afreen S; Department of Parasitology and Emerging Infections, International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh. Ferdous T; Department of Parasitology and Emerging Infections, International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh. Haque R; Department of Parasitology and Emerging Infections, International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh. KirkpatrickBD; Translational Global Infectious Diseases Research Center, University of Vermont Larner College of Medicine, Burlington, Vermont, USA.; Department of Microbiology and Molecular Genetics, University of Vermont Larner College of Medicine, Burlington, Vermont, USA.
Oral rotavirus vaccine shedding as a marker of mucosal immunity.
Autorzy:
Lee B; Translational Global Infectious Diseases Research Center, Larner College of Medicine, University of Vermont, 95 Carrigan Drive, Stafford 208, Burlington, VT, 05405, USA. .; Department of Pediatrics, Larner College of Medicine, University of Vermont, Burlington, VT, USA. . Kader MA; International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh. Colgate ER; Translational Global Infectious Diseases Research Center, Larner College of Medicine, University of Vermont, 95 Carrigan Drive, Stafford 208, Burlington, VT, 05405, USA.; Department of Microbiology and Molecular Genetics, Larner College of Medicine, University of Vermont, Burlington, VT, USA. Carmolli M; Department of Microbiology and Molecular Genetics, Larner College of Medicine, University of Vermont, Burlington, VT, USA. Dickson DM; Translational Global Infectious Diseases Research Center, Larner College of Medicine, University of Vermont, 95 Carrigan Drive, Stafford 208, Burlington, VT, 05405, USA.; Department of Microbiology and Molecular Genetics, Larner College of Medicine, University of Vermont, Burlington, VT, USA. Diehl SA; Department of Microbiology and Molecular Genetics, Larner College of Medicine, University of Vermont, Burlington, VT, USA. Alam M; International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh. Afreen S; International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh. Mychaleckyj JC; Center for Public Health Genomics and Department of Public Health Sciences, University of Virginia, Charlottesville, VA, USA. Nayak U; Center for Public Health Genomics and Department of Public Health Sciences, University of Virginia, Charlottesville, VA, USA. Petri WA Jr; Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, VA, USA. Haque R; International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh. KirkpatrickBD; Translational Global Infectious Diseases Research Center, Larner College of Medicine, University of Vermont, 95 Carrigan Drive, Stafford 208, Burlington, VT, 05405, USA.; Department of Microbiology and Molecular Genetics, Larner College of Medicine, University of Vermont, Burlington, VT, USA.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2021 Nov 05; Vol. 11 (1), pp. 21760. Date of Electronic Publication: 2021 Nov 05.
Typ publikacji:
Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Kinetics and isotype assessment of antibodies targeting the spike protein receptor-binding domain of severe acute respiratory syndrome-coronavirus-2 in COVID-19 patients as a function of age, biological sex and disease severity.
Autorzy:
Graham NR; Department of Microbiology and Molecular Genetics Larner College of Medicine, University of Vermont Burlington VT USA.; Vaccine Testing Center Larner College of Medicine, University of Vermont Burlington VT USA. Whitaker AN; Department of Medicine-Immunobiology Larner College of Medicine, University of Vermont Burlington VT USA.; Cellular, Molecular, and Biomedical Sciences Graduate Program University of Vermont Burlington VT USA.; Vermont Center for Immunology and Infectious Disease Larner College of Medicine, University of Vermont Burlington VT USA. Strother CA; Department of Microbiology and Molecular Genetics Larner College of Medicine, University of Vermont Burlington VT USA.; Cellular, Molecular, and Biomedical Sciences Graduate Program University of Vermont Burlington VT USA. Miles AK; Department of Microbiology and Molecular Genetics Larner College of Medicine, University of Vermont Burlington VT USA.; Vaccine Testing Center Larner College of Medicine, University of Vermont Burlington VT USA. Grier D; Department of Pathology and Laboratory Medicine Larner College of Medicine, University of Vermont Burlington VT USA. McElvany BD; Department of Microbiology and Molecular Genetics Larner College of Medicine, University of Vermont Burlington VT USA.; Vaccine Testing Center Larner College of Medicine, University of Vermont Burlington VT USA. Bruce EA; Department of Medicine-Immunobiology Larner College of Medicine, University of Vermont Burlington VT USA.; Vermont Center for Immunology and Infectious Disease Larner College of Medicine, University of Vermont Burlington VT USA.; Translational Global Infectious Disease Research Center University of Vermont Burlington VT USA. Poynter ME; Cellular, Molecular, and Biomedical Sciences Graduate Program University of Vermont Burlington VT USA.; Vermont Center for Immunology and Infectious Disease Larner College of Medicine, University of Vermont Burlington VT USA.; Translational Global Infectious Disease Research Center University of Vermont Burlington VT USA.; Vermont Lung Center Larner College of Medicine, University of Vermont Burlington VT USA.; Department of Medicine-Pulmonary and Critical Care Larner College of Medicine, University of Vermont Burlington VT USA. Pierce KK; Department of Microbiology and Molecular Genetics Larner College of Medicine, University of Vermont Burlington VT USA.; Vaccine Testing Center Larner College of Medicine, University of Vermont Burlington VT USA.; Translational Global Infectious Disease Research Center University of Vermont Burlington VT USA.; Department of Medicine-Infectious Disease Larner College of Medicine University of Vermont Burlington VT USA. KirkpatrickBD; Department of Microbiology and Molecular Genetics Larner College of Medicine, University of Vermont Burlington VT USA.; Vaccine Testing Center Larner College of Medicine, University of Vermont Burlington VT USA.; Vermont Center for Immunology and Infectious Disease Larner College of Medicine, University of Vermont Burlington VT USA.; Translational Global Infectious Disease Research Center University of Vermont Burlington VT USA.; Department of Medicine-Infectious Disease Larner College of Medicine University of Vermont Burlington VT USA. Stapleton RD; Vermont Lung Center Larner College of Medicine, University of Vermont Burlington VT USA.; Department of Medicine-Pulmonary and Critical Care Larner College of Medicine, University of Vermont Burlington VT USA. An G; Translational Global Infectious Disease Research Center University of Vermont Burlington VT USA.; Department of Surgery Larner College of Medicine, University of Vermont Burlington VT USA. van den Broek-Altenburg E; Department of Radiology Larner College of Medicine, University of Vermont Burlington VT USA. Botten JW; Department of Microbiology and Molecular Genetics Larner College of Medicine, University of Vermont Burlington VT USA.; Vaccine Testing Center Larner College of Medicine, University of Vermont Burlington VT USA.; Department of Medicine-Immunobiology Larner College of Medicine, University of Vermont Burlington VT USA.; Cellular, Molecular, and Biomedical Sciences Graduate Program University of Vermont Burlington VT USA.; Vermont Center for Immunology and Infectious Disease Larner College of Medicine, University of Vermont Burlington VT USA.; Translational Global Infectious Disease Research Center University of Vermont Burlington VT USA. Crothers JW; Vermont Center for Immunology and Infectious Disease Larner College of Medicine, University of Vermont Burlington VT USA.; Translational Global Infectious Disease Research Center University of Vermont Burlington VT USA.; Department of Medicine-Infectious Disease Larner College of Medicine University of Vermont Burlington VT USA. Diehl SA; Department of Microbiology and Molecular Genetics Larner College of Medicine, University of Vermont Burlington VT USA.; Vaccine Testing Center Larner College of Medicine, University of Vermont Burlington VT USA.; Cellular, Molecular, and Biomedical Sciences Graduate Program University of Vermont Burlington VT USA.; Vermont Center for Immunology and Infectious Disease Larner College of Medicine, University of Vermont Burlington VT USA.; Translational Global Infectious Disease Research Center University of Vermont Burlington VT USA.
Pokaż więcej
Źródło:
Clinical & translational immunology [Clin Transl Immunology] 2020 Oct 07; Vol. 9 (10), pp. e1189. Date of Electronic Publication: 2020 Oct 07 (Print Publication: 2020).
Direct RT-qPCR detection of SARS-CoV-2 RNA from patient nasopharyngeal swabs without an RNA extraction step.
Autorzy:
Bruce EA; Division of Immunobiology, Department of Medicine, Robert Larner, M.D. College of Medicine, University of Vermont, Burlington, Vermont, United States of America. Huang ML; Virology Division, Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, United States of America. Perchetti GA; Virology Division, Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, United States of America. Tighe S; Vermont Integrative Genomics Resource, Robert Larner, M.D. College of Medicine, University of Vermont, Burlington, Vermont, United States of America. Laaguiby P; Vermont Integrative Genomics Resource, Robert Larner, M.D. College of Medicine, University of Vermont, Burlington, Vermont, United States of America. Hoffman JJ; Vermont Integrative Genomics Resource, Robert Larner, M.D. College of Medicine, University of Vermont, Burlington, Vermont, United States of America. Gerrard DL; Department of Pathology and Laboratory Medicine, University of Vermont Medical Center, Burlington, Vermont, United States of America. Nalla AK; Virology Division, Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, United States of America. Wei Y; Virology Division, Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, United States of America. Greninger AL; Virology Division, Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, United States of America.; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America. Diehl SA; Department of Microbiology and Molecular Genetics, Robert Larner, M.D. College of Medicine, University of Vermont, Burlington, Vermont, United States of America.; Vaccine Testing Center, Robert Larner, M.D. College of Medicine, University of Vermont, Burlington, Vermont, United States of America. Shirley DJ; Data Science Division, IXIS, Burlington, Vermont, United States of America. Leonard DGB; Department of Pathology and Laboratory Medicine, Robert Larner, M.D. College of Medicine, University of Vermont, Burlington, Vermont, United States of America.; University of Vermont Health Network, Burlington, Vermont, United States of America. Huston CD; Department of Microbiology and Molecular Genetics, Robert Larner, M.D. College of Medicine, University of Vermont, Burlington, Vermont, United States of America.; Division of Infectious Disease, Department of Medicine, University of Vermont Medical Center, Burlington, Vermont, United States of America. KirkpatrickBD; Department of Microbiology and Molecular Genetics, Robert Larner, M.D. College of Medicine, University of Vermont, Burlington, Vermont, United States of America.; Vaccine Testing Center, Robert Larner, M.D. College of Medicine, University of Vermont, Burlington, Vermont, United States of America.; Division of Infectious Disease, Department of Medicine, University of Vermont Medical Center, Burlington, Vermont, United States of America. Dragon JA; Vermont Integrative Genomics Resource, Robert Larner, M.D. College of Medicine, University of Vermont, Burlington, Vermont, United States of America.; Department of Microbiology and Molecular Genetics, Robert Larner, M.D. College of Medicine, University of Vermont, Burlington, Vermont, United States of America. Crothers JW; Department of Pathology and Laboratory Medicine, Robert Larner, M.D. College of Medicine, University of Vermont, Burlington, Vermont, United States of America.; University of Vermont Health Network, Burlington, Vermont, United States of America. Jerome KR; Virology Division, Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, United States of America.; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America. Botten JW; Division of Immunobiology, Department of Medicine, Robert Larner, M.D. College of Medicine, University of Vermont, Burlington, Vermont, United States of America.; Department of Microbiology and Molecular Genetics, Robert Larner, M.D. College of Medicine, University of Vermont, Burlington, Vermont, United States of America.; Vaccine Testing Center, Robert Larner, M.D. College of Medicine, University of Vermont, Burlington, Vermont, United States of America.
Pokaż więcej
Źródło:
PLoS biology [PLoS Biol] 2020 Oct 02; Vol. 18 (10), pp. e3000896. Date of Electronic Publication: 2020 Oct 02 (Print Publication: 2020).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Association of breast milk gamma-linolenic acid with infant anthropometric outcomes in urban, low-income Bangladeshi families: a prospective, birth cohort study.
Autorzy:
Mychaleckyj JC; Department of Public Health Sciences, University of Virginia, Charlottesville, VA, 22908, USA.; Center for Public Health Genomics, University of Virginia, Charlottesville, VA, 22908, USA. Zhang D; Center for Public Health Genomics, University of Virginia, Charlottesville, VA, 22908, USA. Nayak U; Department of Public Health Sciences, University of Virginia, Charlottesville, VA, 22908, USA.; Center for Public Health Genomics, University of Virginia, Charlottesville, VA, 22908, USA. Ross Colgate E; Department of Microbiology and Molecular Genetics, Vaccine Testing Center, University of Vermont Larner College of Medicine, Burlington, VT, USA. Carmolli M; Department of Microbiology and Molecular Genetics, Vaccine Testing Center, University of Vermont Larner College of Medicine, Burlington, VT, USA. Dickson D; Department of Microbiology and Molecular Genetics, Vaccine Testing Center, University of Vermont Larner College of Medicine, Burlington, VT, USA. Ahmed T; International Center for Diarrhoeal Disease Research, Dhaka, Bangladesh. Alam M; International Center for Diarrhoeal Disease Research, Dhaka, Bangladesh. KirkpatrickBD; Department of Microbiology and Molecular Genetics, Vaccine Testing Center, University of Vermont Larner College of Medicine, Burlington, VT, USA. Haque R; International Center for Diarrhoeal Disease Research, Dhaka, Bangladesh. Petri WA Jr; Division of Infectious Diseases and International Health, Department of Medicine, Charlottesville, VA, 22908, USA. .; Department of Pathology, University of Virginia, Charlottesville, VA, 22908, USA. .
Immune responses to O-specific polysaccharide (OSP) in North American adults infected with Vibrio cholerae O1 Inaba.
Autorzy:
Hossain M; Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America.; Infectious Diseases Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh. Islam K; Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America.; Infectious Diseases Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh. Kelly M; Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America. Mayo Smith LM; Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America. Charles RC; Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America.; Harvard Medical School, Boston, Massachusetts, United States of America. Weil AA; Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America.; Harvard Medical School, Boston, Massachusetts, United States of America. Bhuiyan TR; Infectious Diseases Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh. Kováč P; National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK), Laboratory of Bioorganic Chemistry (LBC), National Institutes of Health, Bethesda, Maryland, United States of America. Xu P; National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK), Laboratory of Bioorganic Chemistry (LBC), National Institutes of Health, Bethesda, Maryland, United States of America. Calderwood SB; Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America.; Harvard Medical School, Boston, Massachusetts, United States of America. Simon JK; Merck & Co., Inc., Kenilworth, New Jersey, United States of America. Chen WH; Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America. Lock M; PaxVax, Inc., Redwood City, California, United States of America. Lyon CE; Vaccine Testing Center, Departments of Medicine and Microbiology and Molecular Genetics, University of Vermont College of Medicine, Burlington, Vermont, United States of America. KirkpatrickBD; Vaccine Testing Center, Departments of Medicine and Microbiology and Molecular Genetics, University of Vermont College of Medicine, Burlington, Vermont, United States of America. Cohen M; Cincinnati Children's Hospital Medical Center, and the Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, United States of America. Levine MM; Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America. Gurwith M; PaxVax, Inc., Redwood City, California, United States of America. Leung DT; Division of Infectious Diseases, University of Utah School of Medicine, Salt Lake City, Utah, United States of America. Azman AS; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America. Harris JB; Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America.; Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, United States of America. Qadri F; Infectious Diseases Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh. Ryan ET; Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America.; Harvard Medical School, Boston, Massachusetts, United States of America.; Department of Immunology and Infectious Disease, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America.
Pokaż więcej
Źródło:
PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2019 Nov 19; Vol. 13 (11), pp. e0007874. Date of Electronic Publication: 2019 Nov 19 (Print Publication: 2019).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
Increased Fecal Lactobacillus Is Associated With a Positive Glucose Hydrogen Breath Test in Bangladeshi Children.
Autorzy:
Donowitz JR; Division of Pediatric Infectious Diseases, Children's Hospital of Richmond at Virginia Commonwealth University, Richmond, Virginia.; Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, Virginia. Parikh HI; School of Medicine Research Computing, University of Virginia, Charlottesville, Virginia. Taniuchi M; Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, Virginia. Gilchrist CA; Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, Virginia. Haque R; Division of Parasitology, International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh. KirkpatrickBD; Department of Microbiology and Molecular Genetics, and Vaccine Testing Center, University of Vermont College of Medicine, Burlington, Vermont. Alam M; Division of Parasitology, International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh. Kakon SH; Division of Parasitology, International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh. Islam BZ; James P. Grant School of Public Health, Brac University, Dhaka, Bangladesh. Afreen S; Division of Parasitology, International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh. Kabir M; Division of Parasitology, International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh. Nayak U; Center for Public Health Genomics, University of Virginia, Charlottesville, Charlottesville, Virginia. Colgate ER; Department of Microbiology and Molecular Genetics, and Vaccine Testing Center, University of Vermont College of Medicine, Burlington, Vermont. Carmolli MP; Department of Microbiology and Molecular Genetics, and Vaccine Testing Center, University of Vermont College of Medicine, Burlington, Vermont. Petri WA Jr; Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, Virginia.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2019 Jun 01; Vol. 6 (7), pp. ofz266. Date of Electronic Publication: 2019 Jun 01 (Print Publication: 2019).
Role of maternal health and infant inflammation in nutritional and neurodevelopmental outcomes of two-year-old Bangladeshi children.
Autorzy:
Donowitz JR; Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, Virginia, United States of America.; Division of Pediatric Infectious Diseases, Children's Hospital of Richmond at Virginia Commonwealth University, Richmond, Virginia, United States of America. Cook H; Department of Statistics, University of Virginia, Charlottesville, Virginia, United States of America. Alam M; Division of Parasitology, International Centre for Diarrhoeal Disease Research, Bangladesh, (icddr,b), Dhaka, Bangladesh. Tofail F; Child Development Unit, International Centre for Diarrhoeal Disease Research, Bangladesh, (icddr,b), Dhaka, Bangladesh. Kabir M; Division of Parasitology, International Centre for Diarrhoeal Disease Research, Bangladesh, (icddr,b), Dhaka, Bangladesh. Colgate ER; Department of Medicine, University of Vermont College of Medicine, Burlington, Vermont, United States of America. Carmolli MP; Department of Medicine, University of Vermont College of Medicine, Burlington, Vermont, United States of America. KirkpatrickBD; Department of Medicine, University of Vermont College of Medicine, Burlington, Vermont, United States of America. Nelson CA; Division of Developmental Medicine, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.; Harvard Graduate School of Education, Boston, Massachusetts, United States of America. Ma JZ; Department of Public Health Sciences, University of Virginia, Charlottesville, Virginia, United States of America. Haque R; Division of Parasitology, International Centre for Diarrhoeal Disease Research, Bangladesh, (icddr,b), Dhaka, Bangladesh. Petri WA Jr; Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, Virginia, United States of America.
Pokaż więcej
Źródło:
PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2018 May 29; Vol. 12 (5), pp. e0006363. Date of Electronic Publication: 2018 May 29 (Print Publication: 2018).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Anti-O-specific polysaccharide (OSP) immune responses following vaccination with oral cholera vaccine CVD 103-HgR correlate with protection against cholera after infection with wild-type Vibrio cholerae O1 El Tor Inaba in North American volunteers.
Autorzy:
Islam K; Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America.; Infectious Diseases Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh. Hossain M; Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America.; Infectious Diseases Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh. Kelly M; Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America. Mayo Smith LM; Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America. Charles RC; Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America.; Harvard Medical School, Boston, Massachusetts, United States of America. Bhuiyan TR; Infectious Diseases Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh. Kováč P; National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK), Laboratory of Bioorganic Chemistry (LBC), National Institutes of Health, Bethesda, Maryland, United States of America. Xu P; National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK), Laboratory of Bioorganic Chemistry (LBC), National Institutes of Health, Bethesda, Maryland, United States of America. LaRocque RC; Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America.; Harvard Medical School, Boston, Massachusetts, United States of America. Calderwood SB; Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America.; Harvard Medical School, Boston, Massachusetts, United States of America. Simon JK; Merck & Co., Inc., Kenilworth, New Jersey, United States of America. Chen WH; Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America. Haney D; PaxVax, Inc., Redwood City, California, United States of America. Lock M; PaxVax, Inc., Redwood City, California, United States of America. Lyon CE; Vaccine Testing Center, Department of Medicine University of Vermont College of Medicine, Burlington, Vermont, United States of America. KirkpatrickBD; Vaccine Testing Center, Department of Medicine University of Vermont College of Medicine, Burlington, Vermont, United States of America. Cohen M; Cincinnati Children's Hospital Medical Center, and the Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, United States of America. Levine MM; Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America. Gurwith M; PaxVax, Inc., Redwood City, California, United States of America. Harris JB; Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America.; Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, United States of America. Qadri F; Infectious Diseases Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh. Ryan ET; Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America.; Harvard Medical School, Boston, Massachusetts, United States of America.; Department of Immunology and Infectious Disease, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America.
Pokaż więcej
Źródło:
PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2018 Apr 06; Vol. 12 (4), pp. e0006376. Date of Electronic Publication: 2018 Apr 06 (Print Publication: 2018).
Typ publikacji:
Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Clinical endpoints in the controlled human challenge model for Shigella: A call for standardization and the development of a disease severity score.
Autorzy:
Porter CK; Enteric Disease Department, Infectious Disease Directorate, Naval Medical Research Center, Silver Spring, MD, United States of America. Lynen A; Enteric Disease Department, Infectious Disease Directorate, Naval Medical Research Center, Silver Spring, MD, United States of America. Riddle MS; Enteric Disease Department, Infectious Disease Directorate, Naval Medical Research Center, Silver Spring, MD, United States of America. Talaat K; Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, United States of America. Sack D; Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, United States of America. Gutiérrez RL; Enteric Disease Department, Infectious Disease Directorate, Naval Medical Research Center, Silver Spring, MD, United States of America. McKenzie R; School of Medicine, Johns Hopkins University, Baltimore, MD, United States of America. DeNearing B; Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, United States of America. Feijoo B; Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, United States of America. Kaminski RW; Department of Enteric Infections, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America. Taylor DN; Drug Development Global Program, PATH, Seattle, WA, United States of America. KirkpatrickBD; University of Vermont College of Medicine, Vaccine Testing Center, Department of Medicine, Burlington, VT, United States of America. Bourgeois AL; Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, United States of America.; Enteric Vaccine Initiative, PATH, Washington, DC, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2018 Mar 28; Vol. 13 (3), pp. e0194325. Date of Electronic Publication: 2018 Mar 28 (Print Publication: 2018).
Influence of maternal and socioeconomic factors on breast milk fatty acid composition in urban, low-income families.
Autorzy:
Nayak U; Center for Public Health Genomics, University of Virginia, Charlottesville, 22908, Virginia, USA. Kanungo S; National Institute of Cholera and Enteric Diseases, Kolkata, India. Zhang D; Center for Public Health Genomics, University of Virginia, Charlottesville, 22908, Virginia, USA. Ross Colgate E; Department of Medicine and Vaccine Testing Center, University of Vermont College of Medicine, Burlington, Vermont, USA. Carmolli MP; Department of Medicine and Vaccine Testing Center, University of Vermont College of Medicine, Burlington, Vermont, USA. Dey A; International Vaccine Institute, Seoul, South Korea. Alam M; International Center for Diarrhoeal Disease Research, Dhaka, Bangladesh. Manna B; National Institute of Cholera and Enteric Diseases, Kolkata, India. Nandy RK; National Institute of Cholera and Enteric Diseases, Kolkata, India. Kim DR; International Vaccine Institute, Seoul, South Korea. Paul DK; Dr. B.C. Roy Post Graduate Institute of Paediatric Sciences, Kolkata, India. Choudhury S; Dr. B.C. Roy Post Graduate Institute of Paediatric Sciences, Kolkata, India. Sahoo S; Dr. B.C. Roy Post Graduate Institute of Paediatric Sciences, Kolkata, India. Harris WS; OmegaQuant Analytics, Sioux Falls, South Dakota, USA. Wierzba TF; International Vaccine Institute, Seoul, South Korea. Ahmed T; International Center for Diarrhoeal Disease Research, Dhaka, Bangladesh. KirkpatrickBD; Department of Medicine and Vaccine Testing Center, University of Vermont College of Medicine, Burlington, Vermont, USA. Haque R; International Center for Diarrhoeal Disease Research, Dhaka, Bangladesh. Petri WA Jr; Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, 22908, Virginia, USA.; Department of Pathology, University of Virginia, Charlottesville, Virginia, USA, 22908. Mychaleckyj JC; Center for Public Health Genomics, University of Virginia, Charlottesville, 22908, Virginia, USA.; Department of Public Health Sciences, University of Virginia, Charlottesville, 22908, Virginia, USA.
Pokaż więcej
Źródło:
Maternal & child nutrition [Matern Child Nutr] 2017 Oct; Vol. 13 (4). Date of Electronic Publication: 2017 Feb 15.
In a randomized trial, the live attenuated tetravalent dengue vaccine TV003 is well-tolerated and highly immunogenic in subjects with flavivirus exposure prior to vaccination.
Autorzy:
Whitehead SS; Laboratory of Infectious Diseases, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America. Durbin AP; Center for Immunization Research, Johns Hopkins School of Public Health, Baltimore, Maryland; United States of America. Pierce KK; Vaccine Testing Center, Department of Medicine, University of Vermont Larner College of Medicine, Burlington, Vermont, United States of America. Elwood D; Center for Immunization Research, Johns Hopkins School of Public Health, Baltimore, Maryland; United States of America. McElvany BD; Vaccine Testing Center, Department of Medicine, University of Vermont Larner College of Medicine, Burlington, Vermont, United States of America. Fraser EA; Vaccine Testing Center, Department of Medicine, University of Vermont Larner College of Medicine, Burlington, Vermont, United States of America. Carmolli MP; Vaccine Testing Center, Department of Medicine, University of Vermont Larner College of Medicine, Burlington, Vermont, United States of America. Tibery CM; Center for Immunization Research, Johns Hopkins School of Public Health, Baltimore, Maryland; United States of America. Hynes NA; Center for Immunization Research, Johns Hopkins School of Public Health, Baltimore, Maryland; United States of America. Jo M; Center for Immunization Research, Johns Hopkins School of Public Health, Baltimore, Maryland; United States of America. Lovchik JM; Center for Immunization Research, Johns Hopkins School of Public Health, Baltimore, Maryland; United States of America. Larsson CJ; Vaccine Testing Center, Department of Medicine, University of Vermont Larner College of Medicine, Burlington, Vermont, United States of America. Doty EA; Vaccine Testing Center, Department of Medicine, University of Vermont Larner College of Medicine, Burlington, Vermont, United States of America. Dickson DM; Vaccine Testing Center, Department of Medicine, University of Vermont Larner College of Medicine, Burlington, Vermont, United States of America. Luke CJ; Laboratory of Infectious Diseases, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America. Subbarao K; Laboratory of Infectious Diseases, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America. Diehl SA; Vaccine Testing Center, Department of Medicine, University of Vermont Larner College of Medicine, Burlington, Vermont, United States of America. KirkpatrickBD; Vaccine Testing Center, Department of Medicine, University of Vermont Larner College of Medicine, Burlington, Vermont, United States of America.
Pokaż więcej
Źródło:
PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2017 May 08; Vol. 11 (5), pp. e0005584. Date of Electronic Publication: 2017 May 08 (Print Publication: 2017).
Peripheral CD4+ T cell cytokine responses following human challenge and re-challenge with Campylobacter jejuni.
Autorzy:
Fimlaid KA; Department of Microbiology and Molecular Genetics, University of Vermont, Burlington, Vermont, 05405, United States of America; University of Vermont College of Medicine, Vaccine Testing Center and Unit of Infectious Diseases, Burlington, Vermont, United States of America. Lindow JC; University of Vermont College of Medicine, Vaccine Testing Center and Unit of Infectious Diseases, Burlington, Vermont, United States of America. Tribble DR; Infectious Disease Clinical Research Program, Uniformed Services University of the Health Sciences, Bethesda, Maryland, United States of America. Bunn JY; University of Vermont College of Mathematics, Burlington, Vermont, United States of America. Maue AC; Naval Medical Research Center, Enteric Diseases Department, Silver Spring, Maryland, United States of America. KirkpatrickBD; Department of Microbiology and Molecular Genetics, University of Vermont, Burlington, Vermont, 05405, United States of America; University of Vermont College of Medicine, Vaccine Testing Center and Unit of Infectious Diseases, Burlington, Vermont, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2014 Nov 14; Vol. 9 (11), pp. e112513. Date of Electronic Publication: 2014 Nov 14 (Print Publication: 2014).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
